Immunopathological prognostic and predictive factors in prostate cancer

被引：3
|
作者：
Sivridis E. [1 ]
Touloupidis S. [2 ]
Giatromanolaki A. [2 ]
机构：
[1] Department of Pathology, Democritus University of Thrace, Alexandroupolis
[2] Department of Urology, Democritus University of Thrace, Alexandroupolis
来源：
International Urology and Nephrology | 2002年 / 34卷 / 1期
关键词：
Immunohistochemistry; Prognosis; Prostate cancer; Tumor markers;
D O I：
10.1023/A:1021306928664
中图分类号：
学科分类号：
摘要：
Prostate cancer is the leading male malignancy in the Western world. Patients with prostate cancer have an unpredictable clinical course, as three biologically different types of tumor exist. This review summarises some of the recent progress made in understanding the biology of prostate cancer with special reference to the prognostic and predictive role of immunohistochemical markers. The prognostic value of established prognostic variables is also discussed.
引用
收藏
页码：63 / 71
页数：8
相关论文
共 50 条
  • [41] Insignificant prostate cancer: charateristics and predictive factors
    Fugini, Andrea Vismara
    Antonelli, Alessandro
    Giovanessi, Luca
    Gardini, Valentina Casadei
    Abuhilal, Mohannad
    Zambolin, Tiziano
    Tardanico, Regina
    Simeone, Claudio
    Cunico, Sergio Cosciani
    UROLOGIA JOURNAL, 2011, 78 (03) : 184 - 186
  • [42] Molecular and genetic prognostic factors of prostate cancer
    Chakravarti, A
    Zhai, GG
    WORLD JOURNAL OF UROLOGY, 2003, 21 (04) : 265 - 274
  • [43] PROGNOSTIC FACTORS IN METASTATIC PROSTATE-CANCER
    MATZKIN, H
    PERITO, PE
    SOLOWAY, MS
    CANCER, 1993, 72 (12) : 3788 - 3792
  • [44] Prognostic factors in the pathological assessment of prostate cancer
    Murphy, WM
    HUMAN PATHOLOGY, 1998, 29 (05) : 427 - 430
  • [45] PROGNOSTIC FACTORS OF METASTASIS FOR NONPALPABLE PROSTATE CANCER
    Samycha, J.
    Chaidir, A. M.
    Rainy, U.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 280 - 280
  • [46] Molecular and genetic prognostic factors of prostate cancer
    Arnab Chakravarti
    Gary Guotang Zhai
    World Journal of Urology, 2003, 21 : 265 - 274
  • [47] Molecular biomarkers and prognostic factors for prostate cancer
    Kretschmer, A.
    Tolkach, Y.
    Ellinger, J.
    Kristiansen, G.
    UROLOGE, 2017, 56 (07): : 933 - 943
  • [48] Diagnostic and prognostic factors in patients with prostate cancer
    Beyer, K.
    Moris, L.
    Lardas, M.
    Haire, A.
    Barletta, F.
    Scuderi, S.
    Molnar, M.
    Herrera, R.
    Rauf, A.
    Campi, R.
    Greco, I.
    Shiranov, K.
    Dabestani, S.
    Van den Broeck, T.
    Gacci, M.
    Gandaglia, G.
    Omar, M. I.
    Maclennan, S.
    Roobol, M. J.
    Zong, J.
    Maclennan, S. J.
    Collette, L.
    Briganti, A.
    Bjartell, A.
    Van Hemelrijck, M.
    EUROPEAN UROLOGY, 2021, 79 : S428 - S429
  • [49] Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel
    Yokom, Daniel W.
    Stewart, John
    Alimohamed, Nimira S.
    Winquist, Eric
    Berry, Scott
    Hubay, Stacey
    Lattouf, Jean-Baptiste
    Leonard, Helene
    Girolametto, Carla
    Saad, Fred
    Sridhar, Srikala S.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (08): : E365 - E372
  • [50] Identifying Prognostic and Predictive Gene Alterations in Metastatic Prostate Cancer
    Tafe, L.
    Goyette, E.
    Pettus, J.
    Devitskiy, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S69 - S69
12345